(Total Views: 664)
Posted On: 03/01/2024 4:52:51 PM
Post# of 153988
Finally, the word is accurately breaking through. Old news for all of us, of course.
“ It is a competitive rather than allosteric inhibitor of the CCR5 receptor. This mechanism of action of binding competitively to the CCR5 receptor differentiates leronlimab from all other CCR5 antagonists.”
“ It is a competitive rather than allosteric inhibitor of the CCR5 receptor. This mechanism of action of binding competitively to the CCR5 receptor differentiates leronlimab from all other CCR5 antagonists.”
(5)
(0)
